Priscilla Merriam, MD

Medical Oncologist
Dana-Farber Cancer Institute
Boston, Massachusetts, United States

Clinical Director, Sarcoma Center
Senior Physician, Dana-Farber Cancer Institute
Instructor in Medicine, Harvard Medical School

Presentation(s):

• Paper 80 - DEFI: A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL OF NIROGACESTAT VERSUS PLACEBO FOR PROGRESSING DESMOID TUMORS/AGGRESSIVE FIBROMATOSIS

  Saturday, November 19, 2022
  1:30 PM – 1:42 PM